PRODUCTS SERVICES COMPANY CONTACT FAQ

Search Dictionary Mobile

Login

Michael Boeckh Selected Research

Infection

09/2007	Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection.
04/2007	Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection.
11/2006	Prevention of VZV infection in immunosuppressed patients using antiviral agents.
10/2006	Postexposure prophylaxis against varicella zoster virus infection among hematopoietic stem cell transplant recipients.
03/2006	Brief communication: fatal human metapneumovirus infection in stem-cell transplant recipients.
12/2005	Emerging viral infections after hematopoietic cell transplantation.
12/2004	BK virus infection in hematopoietic stem cell transplant recipients: frequency, risk factors, and association with postengraftment hemorrhagic cystitis.
11/2004	Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy.
09/2004	Pretransplantation respiratory syncytial virus infection: impact of a strategy to delay transplantation.
08/2004	Immune evasion proteins of human cytomegalovirus do not prevent a diverse CD8+ cytotoxic T-cell response in natural infection.
07/2004	Postexposure prophylaxis against varicella-zoster virus infection among recipients of hematopoietic stem cell transplant: unresolved issues.
06/2004	Recent advances in the prevention of CMV infection and disease after hematopoietic stem cell transplantation.
02/2004	Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants.
01/2004	Prolonged outbreak of human parainfluenza virus 3 infection in a stem cell transplant outpatient department: insights from molecular epidemiologic analysis.
08/2003	Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning.
05/2003	Rhinovirus infections in hematopoietic stem cell transplant recipients with pneumonia.
11/2002	Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors.
02/2002	High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection.

Articles by Research Topic

Disease

18	Infection 09/2007 - 02/2002
4	Cytomegalovirus Infections (Inclusion Disease) 06/2008 - 01/2002
3	Aspergillosis 02/2007 - 12/2002
2	Cystitis 08/2005 - 12/2004
1	Paramyxoviridae Infections (Parainfluenza) 09/2007
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2007
1	Leukemia 10/2006
1	Graft vs Host Disease (Graft-Versus-Host Disease) 05/2006
1	Human Influenza (Influenza) 11/2004
1	Pneumonia (Pneumonitis) 10/2003
1	Syndrome 10/2003
1	Adenoviridae Infections (Adenovirus Infections) 05/2003

Drug/Important Bio-Agent (IBA)

2	Ganciclovir (Cytovene)FDA LinkGeneric 05/2003 - 01/2002
1	maribavirIBA 06/2008
1	Ribavirin (Virazole)FDA LinkGeneric 01/2007
1	Antiviral Agents (Antivirals)IBA 11/2006
1	Busulfan (Busulfex)FDA Link 05/2006
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2006
1	thymoglobulinIBA 05/2006
1	Viral DNAIBA 08/2005
1	Proteins (Proteins, Gene)IBA 08/2004
1	Fluconazole (Zonal)FDA LinkGeneric 02/2004
1	Itraconazole (Sporanox)FDA LinkGeneric 02/2004

Therapy/Procedure

10	Transplants (Transplant) 09/2007 - 02/2002
9	Transplantation (Transplant Recipients) 06/2008 - 01/2002
5	Hematopoietic Stem Cell Transplantation 11/2004 - 05/2003
3	Cell Transplantation 02/2007 - 12/2005
2	Stem Cell Transplantation 11/2003 - 03/2002